|
|
|
|
LEADER |
01789nam a2200337 u 4500 |
001 |
EB001999908 |
003 |
EBX01000000000000001162809 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Banerjee, Srabani
|
245 |
0 |
0 |
|a Injectable opioid agonist treatment for patients with opioid dependence
|h Elektronische Ressource
|b : a review of clinical and cost-effectiveness
|c authors: Srabani Banerjee, Mary-Doug Wright
|
250 |
|
|
|a Version: 1.0
|
260 |
|
|
|a Ottawa
|b CADTH
|c 2020, May 27, 2020
|
300 |
|
|
|a 1 PDF file (28 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Analgesics, Opioid / therapeutic use
|
653 |
|
|
|a Cost-Benefit Analysis
|
653 |
|
|
|a Opiate Substitution Treatment / methods
|
653 |
|
|
|a Analgesics, Opioid / administration & dosage
|
653 |
|
|
|a Opioid-Related Disorders / drug therapy
|
653 |
|
|
|a Treatment Outcome
|
700 |
1 |
|
|a Wright, Mary-Doug
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report : summary with critical appraisal
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK564232
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The purpose of this review is to summarize the evidence on the clinical effectiveness and cost-effectiveness of injectable opioid agonist treatment (with DAM or HDM, alone or in combination with methadone or buprenorphine/naloxone), compared with alternative pharmacological treatments or no treatment, for individuals with opioid dependency
|